CAPTRUST FINANCIAL ADVISORS - NORTHWEST BIOTHERAPEUTICS IN ownership

NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 13 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of NORTHWEST BIOTHERAPEUTICS IN
ValueSharesWeighting
Q2 2022$11,000
+175.0%
17,624
+180.2%
0.00%
Q1 2022$4,0000.0%6,2900.0%0.00%
Q4 2021$4,000
-50.0%
6,2900.0%0.00%
Q3 2021$8,000
-27.3%
6,290
-19.3%
0.00%
Q2 2021$11,000
-8.3%
7,7900.0%0.00%
Q1 2021$12,000
+71.4%
7,790
+60.6%
0.00%
Q4 2020$7,000
+133.3%
4,852
+4.1%
0.00%
Q3 2020$3,000
+200.0%
4,662
+115.6%
0.00%
Q2 2020$1,0000.0%2,162
-64.0%
0.00%
Q3 2019$1,000
-50.0%
6,0000.0%0.00%
Q2 2019$2,000
-33.3%
6,000
-34.8%
0.00%
Q1 2019$3,0009,2000.00%
Other shareholders
NORTHWEST BIOTHERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Bedell Frazier Investment Counselling, LLC 107,455$540,0000.25%
Family Management Corp 65,875$331,0000.15%
Knoll Capital Management, LLC 67,035$337,0000.13%
Majedie Asset Management Ltd 150,579$757,0000.13%
Bouchey Financial Group Ltd 14,792$84,0000.04%
HYMAN CHARLES D 41,375$208,0000.04%
WOODSTOCK CORP 26,227$132,0000.02%
WEDBUSH SECURITIES INC 25,500$128,0000.02%
Moors & Cabot, Inc. 21,300$107,0000.02%
Airain ltd 27,430$138,0000.01%
View complete list of NORTHWEST BIOTHERAPEUTICS IN shareholders